no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Aberrant expression of nitric oxide synthase III in Alzheimer’s disease: relevance to cerebral vasculopathy and neurodegeneration
|
de la Monte, S.M |
|
2000 |
21 |
2 |
p. 309-319 11 p. |
article |
2 |
A damaged microcirculation contributes to neuronal cell death in Alzheimer’s disease☆
|
Grammas, Paula |
|
2000 |
21 |
2 |
p. 199-205 7 p. |
article |
3 |
Agrin and microvascular damage in Alzheimer’s disease
|
Berzin, Tyler M |
|
2000 |
21 |
2 |
p. 349-355 7 p. |
article |
4 |
A promising approach to the treatment of multi-infarct dementia
|
Walzl, M. |
|
2000 |
21 |
2 |
p. 283-287 5 p. |
article |
5 |
Are Alzheimer’s disease, hypertension, and cerebrocapillary damage related?☆
|
Farkas, Eszter |
|
2000 |
21 |
2 |
p. 235-243 9 p. |
article |
6 |
Are cerebrovascular factors involved in Alzheimer’s disease?
|
Kudo, Takashi |
|
2000 |
21 |
2 |
p. 215-224 10 p. |
article |
7 |
Chronic cerebrovascular ischemia in aged rats: effects on brain metabolic capacity and behavior☆
|
Cada, Amy |
|
2000 |
21 |
2 |
p. 225-233 9 p. |
article |
8 |
Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion
|
Bennett, S.A.L |
|
2000 |
21 |
2 |
p. 207-214 8 p. |
article |
9 |
Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer’s pathogenesis
|
de la Torre, J.C |
|
2000 |
21 |
2 |
p. 331-342 12 p. |
article |
10 |
Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function
|
Ajmani, R.S |
|
2000 |
21 |
2 |
p. 257-269 13 p. |
article |
11 |
Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer’s type: adverse effects on cerebromicrovascular system.
|
Solerte, S.B |
|
2000 |
21 |
2 |
p. 271-281 11 p. |
article |
12 |
How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer’s disease? A review of neuroimaging studies
|
Lehtovirta, Maarit |
|
2000 |
21 |
2 |
p. 293-300 8 p. |
article |
13 |
Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition
|
Maki, Pauline M |
|
2000 |
21 |
2 |
p. 373-383 11 p. |
article |
14 |
Monoamine oxidase-B inhibitors in the treatment of Alzheimers disease
|
Thomas, Tom |
|
2000 |
21 |
2 |
p. 343-348 6 p. |
article |
15 |
Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs
|
Sparks, D.Larry |
|
2000 |
21 |
2 |
p. 363-372 10 p. |
article |
16 |
Perfusion abnormalities in prodromal AD
|
Johnson, Keith A |
|
2000 |
21 |
2 |
p. 289-292 4 p. |
article |
17 |
Preface
|
de la Torre, Jack |
|
2000 |
21 |
2 |
p. iii-iv nvt p. |
article |
18 |
Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia
|
Meyer, John S |
|
2000 |
21 |
2 |
p. 161-169 9 p. |
article |
19 |
Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway
|
Paris, Daniel |
|
2000 |
21 |
2 |
p. 183-197 15 p. |
article |
20 |
The epidemiology of Alzheimer’s disease and vascular dementia in Japanese and African-American populations: the search for etiological clues
|
Shadlen, Marie-Florence |
|
2000 |
21 |
2 |
p. 171-181 11 p. |
article |
21 |
The role of apolipoprotein E in Alzheimer’s disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models
|
Horsburgh, Karen |
|
2000 |
21 |
2 |
p. 245-255 11 p. |
article |
22 |
The role of cerebral ischemia in Alzheimer’s disease
|
Kalaria, Raj N |
|
2000 |
21 |
2 |
p. 321-330 10 p. |
article |
23 |
Vascular abnormalities: the insidious pathogenesis of Alzheimer’s disease☆
|
Shi, Jiong |
|
2000 |
21 |
2 |
p. 357-361 5 p. |
article |
24 |
Vascular and metabolic reserve in Alzheimer’s disease
|
Nagata, Ken |
|
2000 |
21 |
2 |
p. 301-307 7 p. |
article |
25 |
Vascular risk factors for Alzheimer’s disease:
|
Breteler, Monique M.B |
|
2000 |
21 |
2 |
p. 153-160 8 p. |
article |